337 related articles for article (PubMed ID: 27660893)
21. Cytotoxic ribosome-inactivating lectins from plants.
Hartley MR; Lord JM
Biochim Biophys Acta; 2004 Sep; 1701(1-2):1-14. PubMed ID: 15450171
[TBL] [Abstract][Full Text] [Related]
22. Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity.
Rudolph MJ; Vance DJ; Kelow S; Angalakurthi SK; Nguyen S; Davis SA; Rong Y; Middaugh CR; Weis DD; Dunbrack R; Karanicolas J; Mantis NJ
Protein Eng Des Sel; 2018 Jul; 31(7-8):277-287. PubMed ID: 30265352
[TBL] [Abstract][Full Text] [Related]
23. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).
O'Hara JM; Kasten-Jolly JC; Reynolds CE; Mantis NJ
Immunol Lett; 2014; 158(1-2):7-13. PubMed ID: 24269767
[TBL] [Abstract][Full Text] [Related]
24. A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking.
Herrera C; Klokk TI; Cole R; Sandvig K; Mantis NJ
PLoS One; 2016; 11(6):e0156893. PubMed ID: 27300140
[TBL] [Abstract][Full Text] [Related]
25. Ricin. Mechanisms of cytotoxicity.
Lord MJ; Jolliffe NA; Marsden CJ; Pateman CS; Smith DC; Spooner RA; Watson PD; Roberts LM
Toxicol Rev; 2003; 22(1):53-64. PubMed ID: 14579547
[TBL] [Abstract][Full Text] [Related]
26. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen.
Thomas JC; O'Hara JM; Hu L; Gao FP; Joshi SB; Volkin DB; Brey RN; Fang J; Karanicolas J; Mantis NJ; Middaugh CR
Hum Vaccin Immunother; 2013 Apr; 9(4):744-52. PubMed ID: 23563512
[TBL] [Abstract][Full Text] [Related]
27. Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies.
Bazzoli A; Vance DJ; Rudolph MJ; Rong Y; Angalakurthi SK; Toth RT; Middaugh CR; Volkin DB; Weis DD; Karanicolas J; Mantis NJ
Proteins; 2017 Nov; 85(11):1994-2008. PubMed ID: 28718923
[TBL] [Abstract][Full Text] [Related]
28. Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin's binding subunit.
Rong Y; Van Slyke G; Vance DJ; Westfall J; Ehrbar D; Mantis NJ
PLoS One; 2017; 12(7):e0180999. PubMed ID: 28700745
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the development of vaccines against ricin.
Brey RN; Mantis NJ; Pincus SH; Vitetta ES; Smith LA; Roy CJ
Hum Vaccin Immunother; 2016 May; 12(5):1196-201. PubMed ID: 26810367
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin's Enzymatic Subunit Interfere with Intracellular Toxin Transport.
Yermakova A; Klokk TI; O'Hara JM; Cole R; Sandvig K; Mantis NJ
Sci Rep; 2016 Mar; 6():22721. PubMed ID: 26949061
[TBL] [Abstract][Full Text] [Related]
31. Intracellular Transport and Cytotoxicity of the Protein Toxin Ricin.
Sowa-Rogozińska N; Sominka H; Nowakowska-Gołacka J; Sandvig K; Słomińska-Wojewódzka M
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31216687
[TBL] [Abstract][Full Text] [Related]
32. Finding a new vaccine in the ricin protein fold.
Olson MA; Carra JH; Roxas-Duncan V; Wannemacher RW; Smith LA; Millard CB
Protein Eng Des Sel; 2004 Apr; 17(4):391-7. PubMed ID: 15187223
[TBL] [Abstract][Full Text] [Related]
33. Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin.
Falach R; Sapoznikov A; Alcalay R; Aftalion M; Ehrlich S; Makovitzki A; Agami A; Mimran A; Rosner A; Sabo T; Kronman C; Gal Y
Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30424519
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies.
Herrera C; Tremblay JM; Shoemaker CB; Mantis NJ
J Biol Chem; 2015 Nov; 290(46):27880-9. PubMed ID: 26396190
[TBL] [Abstract][Full Text] [Related]
35. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
[TBL] [Abstract][Full Text] [Related]
36. Immunity to ricin: fundamental insights into toxin-antibody interactions.
O'Hara JM; Yermakova A; Mantis NJ
Curr Top Microbiol Immunol; 2012; 357():209-41. PubMed ID: 22113742
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of Kupffer cells and liver sinusoidal endothelial cells to ricin toxin and ricin toxin-Ab complexes.
Mooney B; Torres-Velez FJ; Doering J; Ehrbar DJ; Mantis NJ
J Leukoc Biol; 2019 Nov; 106(5):1161-1176. PubMed ID: 31313388
[TBL] [Abstract][Full Text] [Related]
38. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.
Neal LM; O'Hara J; Brey RN; Mantis NJ
Infect Immun; 2010 Jan; 78(1):552-61. PubMed ID: 19858297
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.
O'Hara JM; Brey RN; Mantis NJ
Clin Vaccine Immunol; 2013 Jun; 20(6):789-94. PubMed ID: 23515013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
